Pharmaceutical composition

TW202639174APending Publication Date: 2026-10-01NOVARTIS AG
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
TW114146485
Authority / Receiving Office
TW · TW
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-12-16
Filing Date
2022-01-24
Publication Date
2026-10-01

Smart Images

  • Figure TWG2TA001078593_001
    Figure TWG2TA001078593_001
  • Figure TWG2TA001078593_002
    Figure TWG2TA001078593_002
  • Figure TWG2TA001078593_003
    Figure TWG2TA001078593_003
Patent Text Reader

Abstract

The present invention relates to the field of pharmacy, particularly to a pharmaceutical composition for oral administration comprising a pharmaceutical composition for oral administration comprising: (a) an inert substrate, and (b) a mixture comprising N-(3-(6-amino-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide, or a pharmaceutically acceptable salt thereof, or a free form thereof, and at least one binder. The present invention also relates to a process for preparing said pharmaceutical composition for oral administration; and to the use of said pharmaceutical composition in the manufacture of a medicament.
Need to check novelty before this filing date? Find Prior Art